Tang, Patricia,
Phase II trials [electronic resource] / Patricia Tang. - London : Henry Stewart Talks, 2021. - 1 online resource (1 streaming video file (46 min.) : color, sound). - Cancer therapy : latest thinking in efficacy and toxicity, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Cancer therapy : latest thinking in efficacy and toxicity. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Clinical trial endpoints -- Response rate -- Progression-free survival -- Phase II trial designs -- Randomized phase II -- Enrichment -- Basket and umbrella trials.
Access restricted to subscribers.
Mode of access: World Wide Web.
5589 Henry Stewart Talks
Antineoplastic agents--Development.
Clinical trials--Design.
Drug development.
Antineoplastic Agents--pharmacology.
Clinical Trials, Phase II as Topic.
Endpoint Determination.
Imatinib Mesylate.
Patient Selection.
Randomized Clinical Trials as Topic.
Phase II trials [electronic resource] / Patricia Tang. - London : Henry Stewart Talks, 2021. - 1 online resource (1 streaming video file (46 min.) : color, sound). - Cancer therapy : latest thinking in efficacy and toxicity, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Cancer therapy : latest thinking in efficacy and toxicity. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Clinical trial endpoints -- Response rate -- Progression-free survival -- Phase II trial designs -- Randomized phase II -- Enrichment -- Basket and umbrella trials.
Access restricted to subscribers.
Mode of access: World Wide Web.
5589 Henry Stewart Talks
Antineoplastic agents--Development.
Clinical trials--Design.
Drug development.
Antineoplastic Agents--pharmacology.
Clinical Trials, Phase II as Topic.
Endpoint Determination.
Imatinib Mesylate.
Patient Selection.
Randomized Clinical Trials as Topic.